domingo, 1 de septiembre de 2013

Lung Cancer & Genomics: What do we Know?


Lung Cancer & Genomics: What do we Know?

a body with  a lung
The Lancet features a series of papers on lung cancer.External Web Site Icon Topics include immunotherapy, screening for earlier diagnosis, patient management, and tumour biomarkers and genetics, August 2013
Genetics and biomarkers in personalisation of lung cancer treatment.External Web Site Icon
Rosell R, et al. Lancet, 2013 Aug 24
EGFR mutation tumor analysis has been recommended in personalization of treatment of non-small cell lung cancer by several evidence-based groups. Check out CDC tier 1 genomic applications table for more details
CDC paper: Utilization of epidermal growth factor receptor (EGFR) testing in the United States: Still far from optimalExternal Web Site Icon
Genetics in Medicine (2013)
CDC Lung cancer information
National Cancer Institute: Lung Cancer: Prevention, Genetics, CausesExternal Web Site Icon
Did you know? More than 1000 genes have been reported in relation to lung cancer risk and outcomes, including 53 genomewide association studies. To find out more, visit the HuGE NavigatorExternal Web Site Icon

No hay comentarios:

Publicar un comentario